Kane Biotech's total assets for Q3 2025 were C$2.74M, a decrease of -28.09% from the previous quarter. TSE:KNE total liabilities were C$3.53M for the fiscal quarter, a -12.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.